Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 2, 2022
|
| In: |
The journal of clinical investigation
Year: 2022, Jahrgang: 132, Heft: 9, Pages: 1-4 |
| ISSN: | 1558-8238 |
| DOI: | 10.1172/JCI159473 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1172/JCI159473 Verlag, lizenzpflichtig, Volltext: https://www.jci.org/articles/view/159473 
|
| Verfasserangaben: | Michael R. Shurin and Viktor Umansky |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1807837793 | ||
| 003 | DE-627 | ||
| 005 | 20220820204811.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220627s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1172/JCI159473 |2 doi | |
| 035 | |a (DE-627)1807837793 | ||
| 035 | |a (DE-599)KXP1807837793 | ||
| 035 | |a (OCoLC)1341461641 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Shurin, Michael R. |e VerfasserIn |0 (DE-588)1117166449 |0 (DE-627)871293501 |0 (DE-576)478814054 |4 aut | |
| 245 | 1 | 0 | |a Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy |c Michael R. Shurin and Viktor Umansky |
| 264 | 1 | |c May 2, 2022 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.06.2022 | ||
| 700 | 1 | |a Umansky, Viktor |d 1955- |e VerfasserIn |0 (DE-588)102885756X |0 (DE-627)731733207 |0 (DE-576)376300078 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of clinical investigation |d Ann Arbor, Mich. : ASCJ, 1924 |g 132(2022), 9, Artikel-ID e159473, Seite 1-4 |h Online-Ressource |w (DE-627)316004677 |w (DE-600)2018375-6 |w (DE-576)094950423 |x 1558-8238 |7 nnas |a Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy |
| 773 | 1 | 8 | |g volume:132 |g year:2022 |g number:9 |g elocationid:e159473 |g pages:1-4 |g extent:4 |a Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy |
| 856 | 4 | 0 | |u https://doi.org/10.1172/JCI159473 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.jci.org/articles/view/159473 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220627 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 102885756X |a Umansky, Viktor |m 102885756X:Umansky, Viktor |d 140000 |d 60000 |d 61900 |e 140000PU102885756X |e 60000PU102885756X |e 61900PU102885756X |k 0/140000/ |k 0/60000/ |k 1/60000/61900/ |p 2 |y j | ||
| 999 | |a KXP-PPN1807837793 |e 4156714616 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy","title":"Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy"}],"person":[{"family":"Shurin","given":"Michael R.","roleDisplay":"VerfasserIn","display":"Shurin, Michael R.","role":"aut"},{"role":"aut","display":"Umansky, Viktor","roleDisplay":"VerfasserIn","given":"Viktor","family":"Umansky"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 27.06.2022"],"language":["eng"],"recId":"1807837793","origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"May 2, 2022"}],"id":{"eki":["1807837793"],"doi":["10.1172/JCI159473"]},"name":{"displayForm":["Michael R. Shurin and Viktor Umansky"]},"physDesc":[{"extent":"4 S."}],"relHost":[{"origin":[{"publisherPlace":"Ann Arbor, Mich.","publisher":"ASCJ","dateIssuedKey":"1924","dateIssuedDisp":"1924-"}],"id":{"eki":["316004677"],"zdb":["2018375-6"],"issn":["1558-8238"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"journal of clinical investigation","title":"The journal of clinical investigation","subtitle":"JCI ; the publication of the American Society for Clinical Investigation"}],"pubHistory":["1.1924/25 -"],"titleAlt":[{"title":"JCI"}],"part":{"year":"2022","issue":"9","pages":"1-4","volume":"132","text":"132(2022), 9, Artikel-ID e159473, Seite 1-4","extent":"4"},"note":["Gesehen am 25.01.2022","Fortsetzung der Druck-Ausgabe"],"disp":"Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapyThe journal of clinical investigation","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"316004677","language":["eng"],"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"American Society for Clinical Investigation","role":"isb"}]}]} | ||
| SRT | |a SHURINMICHCROSSTALKB2202 | ||